QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

LAB

QT52Standard BioTools Inc.
NASDAQ·Healthcare·Medical - Devices·USA
Latest market price
0.83
+0.02+2.42%
OverviewShort InterestFilings
LABQT52Standard BioTools Inc.·NASDAQ
OverviewShort InterestFilings
0.83+2.42%
TA
Loading chart...
Screen all →
ABT-0.10%$88.41ISRG+1.14%$406.78SYK+2.21%$307.80MDT+1.54%$79.34BSX+0.76%$45.29EW+0.78%$87.36DXCM+1.74%$72.47RMD+1.26%$188.63
Snapshot
Index-P/E-EPS (ttm)-0.25
Insider Own30.90%
Shs Outstand391.46M
Perf Week-8.51%
Market Cap316.24MForward P/E-EPS next Y-0.09Insider Trans0.14%Shs Float-Perf Month-17.03%
Enterprise Value79.96MPEG-EPS next Q-0.01Inst Own-Short Float-Perf Quarter-13.57%
Income-94618145.00P/S3.67EPS this Y86.80%Inst Trans-Short Ratio-Perf Half Y-44.32%
Sales86.25MP/B0.56EPS next Y-162.58%ROA-14.72%Short Interest-Perf YTD-35.18%
Book/sh1.43P/C-EPS next 5Y-ROE-20.80%52W High1.72 -51.76%Perf Year-18.66%
Cash/sh1.16P/FCF-EPS past 3/5Y-ROIC-7.43%52W Low0.79 5.03%Perf 3Y-
Dividend Est.-EV/EBITDA-0.98Sales past 3/5Y-4.63% -9.24%Gross Margin48.30%Volatility4.66% 5.94%Perf 5Y-
Dividend TTM-EV/Sales0.93EPS Y/Y TTM92.31%Oper. Margin-91.02%ATR (14)0.08Perf 10Y-
Dividend Ex-Date-Quick Ratio11.92Sales Y/Y TTM-50.00%Profit Margin-109.08%RSI (14)38.73Recom2.40
Dividend Gr. 3/5Y-Current Ratio12.36EPS Q/Q-SMA20-17.30%Beta1.65Target Price3.25
Payout0.00%Debt/Eq0.05Sales Q/Q5.00%SMA50-14.71%Rel Volume1.02Prev Close0.81
Employees814LT Debt/Eq0.06EarningsAug 10SMA200-30.75%Avg Volume3.22MPrice0.83
IPO DateFeb 10, 2011Option/ShortNo / NoEPS/Sales Surpr.0.00% 16.67%Net Debt/EBITDA2.90Volume3,287,608Change2.42%
Analyst Ratings
DateActionAnalystRatingTarget
Feb-27-25DowngradeKeybancOverweight → Sector Weight
Apr-04-24ReiteratedJefferies$3.25
Nov-05-19DowngradeJanney Montgomery ScottBuy → Neutral
Oct-17-19UpgradeUBSNeutral → Buy
Jan-02-19UpgradeJanney Montgomery ScottNeutral → Buy
Nov-01-18UpgradePiper SandlerNeutral → Overweight
Feb-04-16UpgradeMizuhoNeutral → Buy
Jan-19-16DowngradeCowen & Co.Outperform → Market Perform
Nov-01-15UpgradeCantor FitzgeraldHold → Buy
Oct-29-15UpgradeCantor FitzgeraldHold → Buy
Latest News
Jun-17-26
Jun-17-2604:42AM
Why La-Z-Boy Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving PremarketBenzinga
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue8785174
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A454390
Gross Profit414384
Selling, General and Administrative Excl. Other98110157
Research and Development222662
Other Operating Expense0040
Operating Income-78-93-175
Interest Expense003
Unusual Expense
———
Non-Operating Income (Expense)93-40
Net Income Before Taxes-88-97-138
Income Taxes-38-381
Consolidated Net Income-94-75-139
Net Income From Continuing Operations-51-59-139
Net Income-94-75-139
EPS (Recurring)-0.25-0.20-0.52
EPS (Basic, Before Extraordinaries)-0.25-0.20-0.52
EPS (Diluted)-0.25-0.20-0.52
EBITDA-81-90-118
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio3.705.75—
Gross Margin47.1350.5948.28
Operating Margin-89.66-109.41-100.57
Net Margin-108.05-88.24-79.89
Shares Outstanding388382353
Market Capitalization322489—
Operating Lease Expense
———
Insider Trading Volume
$0.98$0.92$0.85$0.78$0.72● Close Price0.00M3.48M6.97M10.45M13.93MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Kim Hanjoon AlexChief Financial OfficerApr 06 '26Option Exercise0.00140,36602,800,702Apr 08 12:00 AM
Egholm MichaelPresident & CEOApr 06 '26Option Exercise0.00393,02606,790,596Apr 08 12:00 AM
Casdin Partners Master Fund, L.P.director, 10 percent owner:Dec 04 '25Buy1.45150,000217,02072,100,000Dec 04 12:00 AM
Casdin Partners Master Fund, L.P.director, 10 percent owner:Dec 03 '25Buy1.4475,000108,03771,950,000Dec 04 12:00 AM
Casdin Partners Master Fund, L.P.director, 10 percent owner:Dec 02 '25Buy1.42125,000177,51371,875,000Dec 04 12:00 AM
Casdin Partners Master Fund, L.P.director, 10 percent owner:Nov 25 '25Buy1.307,550,0009,838,40571,750,000Nov 26 12:00 AM
Casdin Partners Master Fund, L.P.director, 10 percent owner:Nov 24 '25Buy1.43150,000214,87564,200,000Nov 26 12:00 AM
Casdin Partners Master Fund, L.P.director, 10 percent owner:Nov 20 '25Buy1.30450,000586,26064,050,000Nov 20 12:00 AM
Casdin Partners Master Fund, L.P.director, 10 percent owner:Nov 19 '25Buy1.28350,000448,91063,600,000Nov 20 12:00 AM
Casdin Partners Master Fund, L.P.director, 10 percent owner:Nov 18 '25Buy1.23275,000339,40563,250,000Nov 20 12:00 AM
Casdin Partners Master Fund, L.P.director, 10 percent owner:Nov 17 '25Buy1.22225,000275,58062,975,000Nov 17 12:00 AM
Casdin Partners Master Fund, L.P.director, 10 percent owner:Nov 14 '25Buy1.24250,000309,80062,750,000Nov 17 12:00 AM
Casdin Partners Master Fund, L.P.director, 10 percent owner:Nov 13 '25Buy1.20450,000541,39562,500,000Nov 17 12:00 AM
Casdin Partners Master Fund, L.P.director, 10 percent owner:Nov 12 '25Buy1.19375,000445,83862,050,000Nov 12 12:00 AM
Casdin Partners Master Fund, L.P.director, 10 percent owner:Nov 11 '25Buy1.20300,000358,80061,675,000Nov 12 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR